BCM
ELAT

BlueCrest Capital Management’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

BlueCrest Capital Management’s Portfolio ELAT Stock Details ELAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-40,080
Closed -$783K – 317
2022
Q4 		$783K Buy
40,080
+2,145
+6% +$43.1K 0.02% 122
2022
Q3 		$793K Buy
37,935
+28,936
+322% +$827K 0.02% 144
2022
Q2 		$288K Sell
8,999
-59,911
-87% -$2.26M 0.01% 160
2022
Q1 		$2.81M Sell
68,910
-31,135
-31% -$1.3M 0.09% 126
2021
Q4 		$4.47M Buy
+100,045
New +$4.81M 0.14% 124
2021
Q2 		– Sell
-54,364
Closed -$2.49M – 620
2021
Q1 		$2.49M Buy
+54,364
New +$2.61M 0.04% 443
2020
Q4 		– Sell
-239,576
Closed -$10.6M – 425
2020
Q3 		$10.6M Buy
+239,576
New +$10.1M 0.39% 69
2020
Q2 		– Sell
-8,620
Closed -$355K – 284
2020
Q1 		$355K Buy
+8,620
New +$413K 0.02% 159

BlueCrest Capital Management's ELAT Position: Q1 2023 in Review

BlueCrest Capital Management sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q1 2023, closing a stake of 40,080 shares — an estimated $783K sold.

BlueCrest Capital Management first reported a position in ELAT in Q1 2020 and held it in 8 quarters. The position peaked at $10.6M in Q3 2020. 0 funds tracked by Wall St. Rank hold ELAT as of Q1 2023.

  • BlueCrest Capital Management reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q1 2023 after selling out during the quarter.
  • BlueCrest Capital Management sold 40,080 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q1 2023, an estimated $783K.
  • BlueCrest Capital Management first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q1 2020 and held it in 8 quarters.
  • BlueCrest Capital Management's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $10.6M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q1 2023.

Based on BlueCrest Capital Management's 13F filing for Q1 2023, filed 15 May 2023.